Clinical Trials Logo

Clinical Trial Summary

To decide whether progesterone supplementation in threatened abortion is a sound practice.


Clinical Trial Description

This study was conducted at Obstetrics and Gynecology Department, Tanta University in the period from January 2018 to December 2018. Patients: Eligible patients (n=190) were randomly allocated into 2 groups; study group who will receive progesterone supplementation (Prog.group) and control group who will receive no treatment (place.group). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03930212
Study type Interventional
Source Tanta University
Contact
Status Completed
Phase Phase 4
Start date January 1, 2018
Completion date December 31, 2018

See also
  Status Clinical Trial Phase
Completed NCT03356964 - Step Down FSH Approach and Late Follicular Phase in Progesterone Level Early Phase 1
Completed NCT03519776 - Variation of Progesterone in IVF Cycles
Recruiting NCT06379113 - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients Phase 2/Phase 3
Recruiting NCT06390904 - GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients Phase 2/Phase 3
Recruiting NCT05316935 - GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients Phase 2/Phase 3
Completed NCT05062135 - Progesterone Action on Endometrium of PCOS N/A